Baylor College of Medicine, Section of Immunology Allergy, Rheumatology and Retrovirology, Department of Pediatrics, Texas Children's Hospital, Houston, TX, USA.
Luis Razetti School of Medicine, Central University of Venezuela, Caracas, Venezuela.
Clin Rev Allergy Immunol. 2019 Oct;57(2):145-165. doi: 10.1007/s12016-018-8689-9.
There are now 354 inborn errors of immunity (primary immunodeficiency diseases (PIDDs)) with 344 distinct molecular etiologies reported according to the International Union of Immunological Sciences (IUIS) (Clin Gastroenterol Hepatol 11: p. 1050-63, 2013, Semin Gastrointest Dis 8: p. 22-32, 1997, J Clin Immunol 38: p. 96-128, 2018). Using the IUIS document as a reference and cross-checking PubMed ( www.ncbi.nlm.nih.pubmed.gov ), we found that approximately one third of the 354 diseases of impaired immunity have a gastrointestinal component [J Clin Immunol 38: p. 96-128, 2018]. Often, the gastrointestinal symptomatology and pathology is the heralding sign of a PIDD; therefore, it is important to recognize patterns of disease which may manifest along the gastrointestinal tract as a more global derangement of immune function. As such, holistic consideration of immunity is warranted in patients with clinically significant gastrointestinal disease. Here, we discuss the manifold presentations and GI-specific complications of PIDDs which could lead patients to seek advice from a variety of clinician specialists. Often, patients with these medical problems will engage general pediatricians, surgeons, gastroenterologists, rheumatologists, and clinical immunologists among others. Following delineation of the presenting concern, accurate and often molecular diagnosis is imperative and a multi-disciplinary approach warranted for optimal management. In this review, we will summarize the current state of understanding of PIDD gastrointestinal disease involvement. We will do so by focusing upon gastrointestinal disease categories (i.e., inflammatory, diarrhea, nodular lymphoid hyperplasia, liver/biliary tract, structural disease, and oncologic disease) with an intent to aid the healthcare provider who may encounter a patient with an as-yet undiagnosed PIDD who presents initially with a gastrointestinal symptom, sign, or problem.
现在有 354 种先天性免疫缺陷(原发性免疫缺陷病(PIDD)),根据国际免疫学联合会(IUIS)报告,有 344 种不同的分子病因。(Clin Gastroenterol Hepatol 11: p. 1050-63, 2013, Semin Gastrointest Dis 8: p. 22-32, 1997, J Clin Immunol 38: p. 96-128, 2018)。我们参考 IUIS 文件并在 PubMed(www.ncbi.nlm.nih.gov/pubmed)上交叉核对,发现大约三分之一的免疫功能受损疾病存在胃肠道成分。(J Clin Immunol 38: p. 96-128, 2018)。通常,胃肠道症状和病理学是 PIDD 的先驱标志;因此,重要的是要识别可能沿着胃肠道表现出的疾病模式,因为这是免疫功能的更全面紊乱。因此,对于有临床意义的胃肠道疾病的患者,需要对免疫功能进行整体考虑。在这里,我们讨论了 PIDD 的多种表现和胃肠道特异性并发症,这些并发症可能导致患者向各种临床专科医生寻求建议。通常,这些医疗问题的患者会寻求儿科医生、外科医生、胃肠病学家、风湿病学家和临床免疫学家等的帮助。在明确提出的关注点之后,准确且通常是分子诊断至关重要,并且需要多学科方法以实现最佳管理。在本综述中,我们将总结当前对 PIDD 胃肠道疾病的理解状态。我们将通过关注胃肠道疾病类别(即炎症性疾病、腹泻、结节性淋巴组织增生、肝胆疾病、结构性疾病和肿瘤性疾病)来进行总结,旨在帮助可能遇到尚未确诊的 PIDD 患者的医疗保健提供者,这些患者最初表现为胃肠道症状、体征或问题。